Background. Cutibacterium (formerly Propionibacterium) acne, residing on skin, hair follicles, and sebaceous glands, can persist in the dermal layer despite standard surgical skin preparations. Traditionally considered a colonizer, it's been increasingly recognized as a cause of surgical site infections (SSI). We aimed to gain further clinical insight into C. acne's role in SSI.
Methods. Study design: retrospective chart review. Study Time: January 1, 2013-December 31, 2017. Study Setting: three hospitals within University of Wisconsin Health network. Case identification: all patients with ≥1 postoperative culture positive for C. acne. We defined SSI by CDC criteria, and collected basic demographic and relevant clinical variables.
Results. We identified 77 patients with C. acne postoperative cultures: neurosurgical (61%), orthopedic (17%), cardiothoracic (9%), general surgery (8%), and other surgical departments (5%). Forty-six (60%) of the patients were male. Time from surgery to positive culture was median 24 days (range: 1-670), with > 30 days in 36% patients. Infection and colonization were present in 77 and 23% of the patients, respectively. Infected patients were more likely to have wound infection on examination , P = 0.004), but had no significant difference in temperature, leukocytosis, or C-reactive protein compared with colonized patients. Additional surgeries for debridement, implant revision, or device re-implantation were needed in 62% of the patients. Length of hospital stay due to SSI was prolonged by median 6 days (range 0-33). Median antibiotic duration was 2 weeks, with 25% patients receiving antibiotics for ≥6 weeks. Infection outcomes included cure (86%), chronic infection (3%), transition to hospice (3%), and recurrence (8%). All six patients with recurrences had neurosurgeries and did not receive antibiotics after the initial positive culture (infection not recognized).
Conclusion. SSI caused by C. acne are associated with significant morbidity, especially in patients undergoing implant-related neurosurgical or orthopedic procedures. Due to low virulence and slow-growing properties, time to infection may be prolonged, and traditional inflammatory markers may be lacking. Early recognition of infection, while challenging, is crucial to improving postoperative patient outcomes.
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Background.
A clinic-based procedure room (PR) is a less restrictive environment compared with the traditional operating room (OR). PRs are increasingly being used for minor surgical procedures. Carpal tunnel release (CTR) is one of the most common surgical procedures in the U.S. Veteran population. It is unknown if there is a difference in the incidence of surgical site infection (SSI) among patients who undergo CTR in the PR vs. OR.
Methods. Patient records were queried using Current Procedural Terminology codes from a single Veterans Affairs Medical Center that underwent clean, elective CTR from October 2014 through April 2017 were reviewed. Demographic and clinical data were obtained through chart extraction. Multivariate logistic regression was used to assess the association between infection and patient demographic characteristics, clinical characteristics, and operating environment. The National Healthcare Safety Network definition for SSI was used.
Results. A total of 312 procedures were included in the analysis; 221 procedures in the OR and 91 in the PR. Mean age was 63 years; 88% male. Sixty-four (21%) smoked, 80 (26%) were diabetic. Mean BMI was 32.9 kg/m 2 . The overall infection rate was 2.88%. After adjusting for covariates, procedure setting was not associated with risk of SSI (P = 0.53; OR = 0.43; 95% CI: 0.03-5.94). Same-wrist revision CTR was a significant predictor of SSI (P = 0.02; OR = 28.21; CI: 1.84-434.57). CTR performed in the OR had a similar risk for SSI compared with CTR performed in the PR. The mean total cost of CTR in the OR was $4,254 as compared with the PR total cost of $417.
Conclusion. The rate of SSI following primary and revision CTR in a high morbidity U.S. Veteran population was 2.88%, much higher than in nonveteran populations with lower morbidity. Other studies have found that pre-procedural optimization of modifiable risk factors such as blood glucose control, smoking status and weight is important. There was no difference in rate of SSI between the OR and PR environments. Revision CTR appears to be higher risk for SSI. A larger sample size is important to validate these findings. Minimally invasive procedures performed in a PR could lead to greater patient satisfaction, access to surgery, higher efficiency, and a 10-fold cost-savings.
Disclosures. All authors: No reported disclosures. Background. Little is known about actual hospital earnings in patients with and without surgical site infections (SSI) under a prospective payment system. To exemplify respective financial incentives for hospitals to prevent SSI, we aimed to compare hospital costs and earnings in colon surgery and coronary artery bypass grafting (CABG) patients, with and without SSI.
Costs vs. Earnings in Colon Surgery
Methods. Based on a national and validated SSI surveillance cohort, we performed a nested financial analysis at a participating tertiary care center in Switzerland. Consecutive patients with colon operations and CABGs from January 2015 through December 2016; and from January 2015 through October 2016, respectively, were included. Co-primary outcome measures were actual hospital costs and earnings under a prospective payment system (SwissDRG), stratified by SSI status. Ascertainment of SSI status was performed as part of a standardized follow-up protocol at 1 month and one year after surgery.
Results. In colon surgery (n = 229), the median costs were $68,796 (interquartile range [IQR] , $39,600-$95,217) with SSI and $26, 556 (IQR, $18, 230) without SSI (unadjusted P < 0.001; adjusted P = 0.001). In CABGs (n = 433), the median costs were $117,170 (IQR, $57, 953) with SSI and $48, 855 (IQR, $40, [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] 860) without SSI (unadjusted P < 0.001; adjusted P < 0.001). In colon surgery, the median earnings were −$10,738 (IQR, −$33,275 to −$3,492) with SSI and −$2,223 (IQR, −$13,009 to $4,917) without SSI (unadjusted P = 0.001; adjusted P = 0.038). In CABG, the median earnings were −$25,050 (IQR, −$54,060 to −$10,882) with SSI and −$2,485 (IQR, −$11,597 to $3,375) without SSI (unadjusted P < 0.001; adjusted P < 0.001). October 6, 2018: 12:30 PM Background. During surgical operations, surgical wounds are classified according to the wound classification system (I-clean; II-clean/contaminated; III-contaminated; and IV-dirty). Accuracy in assessing the degree of wound contamination is crucial since it greatly impacts the risk of a surgical site infection (SSI). Thus, wound classifications (WC) are determinant in calculating the expected number of SSIs. At our institution we suspected that surgical wounds were not always accurately classified, and were skewed toward under-classifying wound class. This contributed to incorrect and reduced expected SSIs and an inflated SSI Standardized Infection Ratio (SIR).
Conclusion.
Methods. An independent team reviewed 273 surgical cases from our top priority SSI reduction areas: Prosthetic knees (KPRO), coronary artery bypass grafts (CABG), abdominal hysterectomies (HYST) and colorectal surgery (COLO). Whenever there was discordance in surgeon vs. review team WC, an arbitrator reviewed the case with the surgeon and corrected misclassified cases as appropriate. Reclassifications were documented in the medical record as well as in the National Healthcare Safety Network (NHSN) system.
Results. Figure 1 shows all WC reviews. Overall, 14% of all surgeries were misclassified and 95% of misclassifications were under-classifications. Appropriateness of WC varied widely by surgical service, with 100% concordant WC for KPRO, while 9% of HYST and CABG were misclassified, and fully 38% of COLOs were misclassified (Figure 1 ). These errors led to under predicting expected SSIs and, if not corrected, would have a measurable impact on our SSI SIR.
Conclusion. The inaccurate classifications vary by service/surgery, but in COLO we found them to be common and overwhelmingly skewed toward under-classification, which had a measurable impact on the number of expected SSIs and on SSI SIR. Focusing efforts on surgeries more prone to misclassification (such as COLO rather than KPRO) may be a worthwhile focused quality improvement effort.
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